国家级新药“蚓激酶”和“蚓激酶胶囊”研制成功
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


A New Medicine of State Level“Luinbrokinase” and “Lumbrokinase Capsule" Has Been Developed and Prepered Success
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    治疗血栓病的持效药“蚓激酶”及“蚓激酶胶囊”由中国科学院生物物理研究所研制成功,该药适用于血栓形成和栓塞病的预防和治疗,尤其对缺血性脑血管病瘫痪及语言障碍的康复效果显著,是一种有前途、安全的纤溶药物.

    Abstract:

    A highly effective medicine for the cure of thrombotic diseases, lumbrokinase and lumbrokinase capsule has been successfully developed and prepsred by sientists in the Institute of Biophysics, Academia Sinica. The medicine is applicable in prevention and treatment of thrombosis and embolic diseases and is especially effective for treatment of ischemic cerebrovascular disorder induced paralysis and language trouble. Notable improvement and recovery were observed among the hosipitalized patients on clinical trail. It is a promissing and specific fibrinolytic medicine safe to use.

    参考文献
    相似文献
    引证文献
引用本文

侯全民.国家级新药“蚓激酶”和“蚓激酶胶囊”研制成功[J].生物化学与生物物理进展,1994,21(1):85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 接受日期:
  • 在线发布日期:
  • 出版日期: